Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
RESEARCH AND DEVELOPMENT FOR IN-SPACE PRODUCTION CONCEPTS OF NANOBIOREACTOR MODELS. THIS WAS AWARDED OFF OF THE NASA RESEARCH ANNOUNCEMENT NNJ13ZBG001N. NOTE THAT "BASIC RESEARCH" IS NOT A SELECTABLE SOLICITATION TYPE FOR PURCHASE ORDERS IN FPDS. is a federal Unrestricted award for Nasa Johnson Space Center held by Aspera Biomedicines, Inc. Estimated value $13M ($6.5M obligated). Current period of performance ends Feb 15, 2028. Last award drew 1 bidder. Place of performance: LA JOLLA CA. Related solicitation NNJ13ZBG001N.
RESEARCH AND DEVELOPMENT FOR IN-SPACE PRODUCTION CONCEPTS OF NANOBIOREACTOR MODELS. THIS WAS AWARDED OFF OF THE NASA RESEARCH ANNOUNCEMENT NNJ13ZBG001N. NOTE THAT "BASIC RESEARCH" IS NOT A SELECTABLE SOLICITATION TYPE FOR PURCHASE ORDERS IN FPDS.
Recompete timing
PublicCurrent PoP ends Feb 15, 2028 (506 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Aug 15, 2026.
Want the durability read on 80JSC025PA001? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordAspera Biomedicines, Inc — $3.2M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 80JSC025PA001?
80JSC025PA001 (Research and development for in-space production) is a Nasa Johnson Space Center award with a potential value of $13M, currently held by Aspera Biomedicines, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 80JSC025PA001?
Nasa Johnson Space Center awarded 80JSC025PA001 to Aspera Biomedicines, Inc (potential $13M).
Who is the incumbent on 80JSC025PA001?
Aspera Biomedicines, Inc is the incumbent with $3.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Feb 15, 2028.
When does Aspera Biomedicines, Inc’s 80JSC025PA001 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 15, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 80JSC025PA001? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.